SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-21-000017
Filing Date
2021-05-12
Accepted
2021-05-12 16:02:24
Documents
16
Period of Report
2021-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20210512.htm   iXBRL 8-K 40014
2 EX-99.1 exhibit991q12021earningsre.htm EX-99.1 69907
8 GRAPHIC image_01.jpg GRAPHIC 286137
  Complete submission text file 0001587221-21-000017.txt   654097

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20210512.xsd EX-101.SCH 2448
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20210512_cal.xml EX-101.CAL 730
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20210512_def.xml EX-101.DEF 1667
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20210512_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20210512_pre.xml EX-101.PRE 12666
9 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20210512_htm.xml XML 10763
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 21915000
SIC: 2834 Pharmaceutical Preparations